Luxfer LXFR
- Market cap
- $460.8M
- PE
- 78.3×
- 7y median 22.5×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.3×
- EV/EBIT
- 22.3×
- Revenue, 12 months
- $362M
- −10% on a year ago
- Net margin
- 1.7%
- Free cash flow yield
- 4.1%
Luxfer trades at 78.3× trailing earnings, pricier than 94% of the last ten years. Revenue was $362M over the last twelve months, down 10% on a year earlier with a 2% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $95.9M−18% | $89.4M−12% | $99.7M−10% | $99.4M+2% | $103.4M+8% | $97M+9% | $106.6M+7% | $95.6M−4% | $90.7M−12% | $83.9M−14% | $95.7M−10% | $91.7M−4% | |
| Cost of revenue | $79.2M−17% | $71M−12% | $77.7M−10% | $77M−7% | $80.5M+2% | $75.6M+7% | $81.9M+5% | $72.8M−6% | $68.6M−15% | $62M−18% | $71.2M−13% | $69.3M−5% |
| Gross profit | $16.7M−24% | $18.4M−13% | $22M−9% | $22.4M+53% | $22.9M+37% | $21.4M+16% | $24.7M+12% | $22.8M+2% | $22.1M−4% | $21.9M+2% | $24.5M−1% | $22.4M−2% |
| R&D | $1.2M−14% | $1.2M+0% | $1.1M+10% | $1M−17% | $1.1M−8% | $1.1M−8% | $1.1M+0% | $900K−10% | $1.2M+9% | $1.4M+27% | $1.6M+46% | $1.4M+56% |
| SG&A | $12.1M+14% | $11.6M−7% | $11.9M−7% | $11.4M+1% | $13.2M+9% | $12.6M+9% | $13.5M+13% | $11.8M+4% | $12.6M−5% | $11.4M−10% | $12.3M−9% | $11.8M+0% |
| −$11.3M | $4.9M−31% | $3.8M−52% | $17.4M+3380% | $4M | $7.6M+55% | $5.2M+37% | $5.6M−68% | $3.3M−18% | $6.2M−18% | $7.8M+50% | $2.8M−50% | |
| Interest expense | $1.6M+33% | $1.4M+8% | $1.3M−28% | $1.4M−13% | $1.1M−31% | $800K−43% | $900K−31% | $700K−50% | $700K−36% | $700K−13% | $1M+11% | $1M+43% |
| Pre-tax income | −$12.5M | $3.8M | $2.7M−60% | $16.3M | $3.7M | $7.4M+95% | $4.9M+82% | $5.5M−66% | $2.1M−43% | $5.5M−26% | $6.7M+37% | $1.7M−69% |
| −$6M | $1M | $3.1M+72% | $3.7M+429% | $400K | $1.9M+90% | $2.3M−26% | $2.8M−24% | $2M+400% | $1.7M−11% | $1.9M−17% | $800K−71% | |
| Net income | −$5.8M | $2.7M+440% | −$500K | $12.7M | $3.5M | $5.5M+104% | $2.6M | $2.7M−79% | −$3.1M | $3.6M−35% | $4.8M+85% | $900K−67% |
| −$0.22 | $0.10+400% | −$0.02 | $0.47 | $0.13 | $0.20+100% | $0.10 | $0.10−79% | −$0.12 | $0.13−35% | $0.18+80% | $0.03−70% | |
| 26.8M−1% | 26.9M−1% | 26.9M−1% | 26.9M−0% | 27.4M+2% | 27.1M+1% | 27.1M+1% | 27.2M+1% | 26.7M−3% | 26.8M−1% | 27.2M+1% | 27.3M+1% |
EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY18 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY20 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Chemicals - Specialty nearest Luxfer's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| LXFRLuxfer | $460.8M | 78.3× | 22.5× | 1.3× | −10% | 1.7% | |
| WLKPWestlake Chemical Partners | $769.1M | 13.4× | 13.7× | 0.6× | +12% | 4.7% | |
| ALTOAlto Ingredients | $271.5M | 5.2× | 13.2× | 0.3× | +1% | 5.5% | |
| LXULSB Industries | $795.6M | 17.8× | 16.9× | 1.2× | +13% | 7.0% | |
| GPREGreen Plains | $966.6M | 8.7× | 26.0× | 0.5× | −24% | 6.8% | |
| REXREX AMERICAN RESOURCES | $1.3B | 10.6× | 16.7× | 2.0× | +1% | 19.7% | |
| Peer median | $795.6M | 10.6× | 16.7× | 0.6× | +1% | 6.8% |
More on Luxfer
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .